BCL2 and breast cancer: Treatment of MDA-MB231 breast cancer cells with low molecular weight fucoidan resulted in a significant decrease in anti-apoptotic proteins Bcl-2, Bcl-xl and Mcl-1 associated with the activation of caspases, mitochondrial dysfunction and alteration of Ca2+ homeostasis [192].